Biopharmaceutical company
AI-generated insights about Macrogenics from various financial sources
A director made a significant insider purchase of $150,000 after a 50% stock drop, which is the first in over a year. The director's last purchase was followed by a 100% stock increase.
A director made a significant insider purchase of $150,000 after a 50% stock drop, which is the first in over a year. The director's last purchase was followed by a 100% stock increase.